Zydus Cadila gets USFDA nod to market generic cancer drug in US

The company has received final approval from the US Food and Drug Administration (USFDA) to Decitabine for Injection in the strength of 50 mg/vial single-dose vial, Zydus Cadila said in a statement.

from Moneycontrol Business News https://ift.tt/3DCW5kr